Orphanet: Simple search
x

Search for a clinical trial

* (*) mandatory field

207 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member = ; Member of a ERN =

National clinical trial(s)

GERMANY

Baden-Württemberg
TÜBINGEN

Recruiting trial
Ongoing trial
An open label, Phase Ia/Ib dose finding study with BI 894999 orally administered once a day in patients with advanced malignancies, with repeated administration in patients with clinical benefit -DE-
Department für Innere Medizin - Medizinische Universitätsklinik Tübingen
Innere Medizin VIII - Medizinische Onkologie und Pneumologie

AUSTRIA

OBERÖSTERREICH
LINZ

AUSTRIA

SALZBURG
SALZBURG

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

FRANCE

NOUVELLE AQUITAINE
BORDEAUX

Recruiting trial
Ongoing trial
Tazemetostat Rollover Study (TRuST): An Open-Label, Rollover Study (Phase II) - FR
CLCC Institut Bergonié
Département d'oncologie médicale - Sarcomes

FRANCE

OCCITANIE
MONTPELLIER

GERMANY

Baden-Württemberg
FREIBURG

Recruiting trial
Ongoing trial
R-CPOP as first line therapy for elderly patients with DLBCL and for patients with limited cardiac function with DLBCL -DE-
Universitätsklinikum Freiburg
Klinik für Innere Medizin I - Hämatologie, Onkologie und Stammzelltransplantation

GERMANY

Baden-Württemberg
HEIDELBERG

Recruiting trial
Ongoing trial
CHARLY: Phase-II study on the value of post-transplant Cyclophosphamide after Thiotepa-based haplo-identical stem-cell transplantation for relapsed-refractory lymphoma
Zentrum für Innere Medizin (Krehl-Klinik)
Abteilung Innere Medizin V - Hämatologie, Onkologie und Rheumatologie

GERMANY

Baden-Württemberg
HEIDELBERG

Recruiting trial
Ongoing trial
Treatment of patients with relapsed or refractory CD19+ lymphoid disease with T lymphocytes transduced by RV-SFG.CD19.CD28.4-1BBzeta retroviral vector - A unicenter Phase I /II clinical trial
Zentrum für Kinder- und Jugendmedizin - Angelika-Lautenschläger-Klinik
Klinik für Kinderheilkunde III - Pädiatrische Onkologie, Hämatologie, Immunologie und Pneumologie

GERMANY

Nordrhein-Westfalen
ESSEN

ITALY

EMILIA ROMAGNA
BOLOGNA

Recruiting trial
Ongoing trial
Study of Lenalidomide(Revlimid) Plus Rituximab (Revlirit Regimen) in Elderly Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Policlinico S. Orsola-Malpighi - Area S. Orsola
Dipartimento di Ematologia e Scienze Oncologiche

ITALY

LAZIO
ROMA

Ongoing trial
PRELUDE: A Phase III Clinical Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
Policlinico Umberto I
Dipartimento di Biotecnologie Cellulari ed Ematologia

SPAIN

Castilla - León
SALAMANCA

SPAIN

Cataluña
BARCELONA

SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Recruiting trial
Ongoing trial
Long Term Follow-Up of Patients Exposed to Lentiviral-Based CD19 directed CAR T-Cell Therapy - ES
Hospital Sant Joan de Déu Barcelona
Servicio de Oncología y Hematología

SPAIN

Madrid
ADDRESS: NOT PROVIDED - ES

SPAIN

Madrid
MADRID

Recruiting trial
Ongoing trial
A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study - ES
Hospital Universitario Fundación Jiménez Díaz
Servicio de Hematología y Hemoterapia

SPAIN

Madrid
MAJADAHONDA

Recruiting trial
Ongoing trial
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib After Completion of Ibrutinib Clinical Trials (Phase IV) - ES
Hospital Universitario Puerta de Hierro - Majadahonda
Servicio de Hematología y Hemoterapia

SPAIN

Madrid
MAJADAHONDA

SPAIN

Navarra
PAMPLONA

Recruiting trial
Ongoing trial
A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study - ES
Clínica Universidad de Navarra
Servicio de Hematología y Hemoterapia

UNITED KINGDOM

Devon
PLYMOUTH

Ongoing trial
A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study - UK
Plymouth Derriford Hospital
British National Lymphoma Institute Research Group

UNITED KINGDOM

Greater London
LONDON

Recruiting trial
Ongoing trial
COBALT: Evaluation of CAR19 T-cells as an Optimal Bridge to Allogeneic Transplantation
UCL Cancer Institute, University College London
Department of Haematology

UNITED KINGDOM

Hampshire
SOUTHAMPTON

Ongoing trial
RiVa: A Phase IIa Study of RItuximab and VArlilumab in Relapsed or Refractory B-cell Malignancies
University of Southampton
School of Medicine (Medical Oncology)

AUSTRIA

SALZBURG
SALZBURG

Recruiting trial
Ongoing trial
B-NHL 2013: Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents (Phase 3) - AT
Universitätsklinikum der Paracelsus Medizinischen Privatuniversität
Universitätsklinik für Kinder- und Jugendheilkunde

GERMANY

Nordrhein-Westfalen
MÜNSTER

Recruiting trial
Ongoing trial
B-NHL 2013: Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents (Phase 3) -DE-
Universitätsklinikum Münster
Klinik für Kinder- und Jugendmedizin - Pädiatrische Hämatologie und Onkologie

FRANCE

AUVERGNE-RHONE-ALPES
PIERRE-BENITE

GERMANY

Nordrhein-Westfalen
KÖLN

GERMANY

Nordrhein-Westfalen
MÜNSTER

Recruiting trial
Ongoing trial
A Phase I/II Safety, Dose Finding and Feasibility Trial of MB-CART19.1 in Patients With Relapsed or Refractory CD19 Positive B Cell Malignancies
Universitätsklinikum Münster
Klinik für Kinder- und Jugendmedizin - Pädiatrische Hämatologie und Onkologie

SPAIN

Madrid
MADRID

Recruiting trial
Ongoing trial
A phase I/II, multicenter, open-label study of MAK683 in adult patients with advanced malignancies - ES
Hospital Universitario 12 de Octubre
Unidad de Ensayos Clínicos de Fase Temprana en Hematología

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Bayern
REGENSBURG

Recruiting trial
Ongoing trial
INFORM2 NivEnt: exploratory multinational phase I/II combination study of Nivolumab and Entinostat in children and adolescents with refractory high-risk malignancies
Universitätsklinikum Regensburg
Abteilung für Pädiatrische Hämatologie, Onkologie und Stammzelltransplantation

GERMANY

Nordrhein-Westfalen
ESSEN

Recruiting trial
Ongoing trial
INFORM2 NivEnt: exploratory multinational phase I/II combination study of Nivolumab and Entinostat in children and adolescents with refractory high-risk malignancies
Universitätsklinikum Essen
Klinik für Kinderheilkunde III - Abteilung für pädiatrische Hämatologie und Onkologie

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Ongoing trial
STEP: Sorafenib Long Term Extension Program - BE
Cliniques universitaires Saint-Luc - UCLouvain
Pneumologie_Oncologie thoracique

Multinational clinical trial(s)

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US